Promises and challenges of organoids : From humanized to human derived
Copyright © 2024 Elsevier Inc. All rights reserved..
Kastenschmidt et al.1 present a groundbreaking organoid culture model for follicular lymphoma, which is capable of maintaining stable compositions of B and T cells. This model is utilized in testing bispecific antibodies in effective killing of tumor B cells with the activation of T cells.
| Errataetall: |
CommentOn: Cell Stem Cell. 2024 Mar 7;31(3):410-420.e4. - PMID 38402619 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Cell stem cell - 31(2024), 3 vom: 07. März, Seite 281-282 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Wenyan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Bispecific |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 22.03.2024 published: Print CommentOn: Cell Stem Cell. 2024 Mar 7;31(3):410-420.e4. - PMID 38402619 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.stem.2024.02.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369479068 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369479068 | ||
| 003 | DE-627 | ||
| 005 | 20240323235255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240309s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.stem.2024.02.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1342.xml |
| 035 | |a (DE-627)NLM369479068 | ||
| 035 | |a (NLM)38458173 | ||
| 035 | |a (PII)S1934-5909(24)00045-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Wenyan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Promises and challenges of organoids |b From humanized to human derived |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Cell Stem Cell. 2024 Mar 7;31(3):410-420.e4. - PMID 38402619 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
| 520 | |a Kastenschmidt et al.1 present a groundbreaking organoid culture model for follicular lymphoma, which is capable of maintaining stable compositions of B and T cells. This model is utilized in testing bispecific antibodies in effective killing of tumor B cells with the activation of T cells | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Bispecific |2 NLM | |
| 700 | 1 | |a Fu, Yang-Xin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell stem cell |d 2007 |g 31(2024), 3 vom: 07. März, Seite 281-282 |w (DE-627)NLM176526269 |x 1875-9777 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2024 |g number:3 |g day:07 |g month:03 |g pages:281-282 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.stem.2024.02.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2024 |e 3 |b 07 |c 03 |h 281-282 | ||